CLOXACILLIN sodium, eq. 500mg base, powder, vial IV
STD
DINJCLOX5VV
Valid Article
Account code:
60000
HS Code:
300410
Last Updated on:
04/10/2024, 17:03:19
Former
Code(s):
-X
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01CF02
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
CLOXACILLIN
Therapeutic Action
Penicillin antibacterial, active against penicillinase-producing staphylococci
Indications
Severe infections due to streptococci and/or staphylococci
Erysipelas, cellulitis
- See: Essential drugs, MSF, 2024
- See: Clinical guidelines, MSF, 2024
- See: Neonatal care, Clinical and Therapeutic guidelines, MSF, 2021
- See: Pathogen-Specific, Targeted Antibiotic Therapy for Bacteremia and Bone and Joint, Urinary Tract, and Central Nervous System Infections. MSF internal protocol, 2019
Instructions for use
Reconstitute the powder vial with 4 ml of water for injection.
The reconstituted solution must be given as IV infusion in 0.9% NaCl or 5% dextrose.
Flucloxacillin, oxacillin and dicloxacillin are similar antibacterials to cloxacillin (same indications and dosage).
Storage
- Below 25°C - Protect from sunlight - Protect from humidity
- After reconstitution, use the solution immediately.